Patients were randomized to stay on their treatment at the time of enrollment or to be switched to MIRCERA in order to maintain stable haemoglobin levels.
Se distribuyó al azar a los pacientes de modo que continuaran con su tratamiento de ese momento o pasaran a recibir MIRCERA a fin de mantener niveles estables de hemoglobina.